| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Previous Article | Next Article ![]()
Journal of Bacteriology, April 2008, p. 3076-3082, Vol. 190, No. 8
0021-9193/08/$08.00+0 doi:10.1128/JB.01766-07
Copyright © 2008, American Society for Microbiology. All Rights Reserved.

Department of Microbial, Biochemical and Food Biotechnology, University of the Free State, Bloemfontein 9300, South Africa
Received 7 November 2007/ Accepted 2 February 2008
| ABSTRACT |
|---|
|
|
|---|
70-like promoter. Sequence analysis shows the chromate reductase to be related to the old yellow enzyme family, in particular the xenobiotic reductases involved in the oxidative stress response. | INTRODUCTION |
|---|
|
|
|---|
The structural similarity of chromate to SO42– allows for the uptake of Cr(VI) into bacteria via the sulfate transport system (5). Intracellular reduction through physiological reducing agents to transiently formed intermediates, such as Cr(V), and related free radical generation are considered to be major causes of Cr(VI) toxicity and carcinogenesis (6, 16). A variety of bacteria have been shown to mediate Cr(VI) reduction, and several enzymes with diverse physiological functions (25), including glutathione reductase, lipoyl reductase, and ferredoxin-NADP+ reductase, have been shown to be able to catalyze chromate reduction. Fortuitous chromate reduction via the nitroreductases (NfsA) of Pseudomonas ambigua, Escherichia coli, and Vibrio harveyi has also been demonstrated (1, 14, 27). The chromate reductases (ChrR) of Pseudomonas putida and E. coli reduce Cr(VI) to Cr(III) (2, 22), but catalytic and sequence similarities indicate these enzymes to be probable quinone reductases. Regardless, these reductases have been shown to be able to protect against chromate toxicity through decreased reactive oxygen species (ROS) formation (2).
Old yellow enzyme (OYE) from Saccharomyces carlsbergensis was the first flavin oxidoreductase identified (32). OYE homologues usually occur as homodimers with a noncovalently bound flavin mononucleotide (FMN) cofactor. The enzyme follows a bi-bi ping-pong mechanism, with NAD(P)H as the presumed physiological reductant. Despite over 70 years of research, the physiological oxidants for OYE as well as most members of the OYE family are still unknown (33). Although molecular oxygen can serve as an electron acceptor, the low reaction rate as well as the production of H2O2 makes it an unlikely physiological oxidant. Other substrates capable of reoxidizing OYE include methylene blue, Fe3+, quinones, cytochrome c, and ferricyanide. Bacterial homologues include, among others, the morphinone reductase (8), xenobiotic reductases (9), and, more recently, the Bacillus subtilis YqjM protein (7). The involvement of many of the OYE homologues in the oxidative stress response as well as the range of electrophilic substrates during reactions, such as the reduction of the olefinic bond of
,β-unsaturated carbonyl compounds, the reductive denitration of aliphatic nitro esters, and the reduction of nitroaromatic compounds, could suggest a detoxification enzyme in the antioxidant defense system (4, 7, 9, 12, 15).
The South African gold mine isolate Thermus scotoductus SA-01 can reduce a variety of heavy metals (11, 18), including Cr(VI) (21). This paper reports the purification, characterization, and sequence analysis of a novel cytoplasmic chromate reductase from T. scotoductus SA-01 related to OYE.
| MATERIALS AND METHODS |
|---|
|
|
|---|
Enzyme assays. Chromate reductase activity was determined by measuring the decrease of hexavalent chromium by the s-diphenylcarbazide method (30). During purification, the enzyme was assayed in 1-ml reaction mixtures containing 20 mM MOPS-NaOH buffer, 10 mM CaCl2 (pH 6.5), 0.1 mM CrO3, 0.3 mM NADPH, and 0.05 ml of the enzyme preparation at 65°C. Samples (0.3 ml) were withdrawn and added to 2.5 ml of a 0.12 M H2SO4 stock solution. A 0.2-ml volume of the sym-diphenylcarbazide reagent (dissolved in acetone) was added to the reaction mixture to a final concentration of 0.4 mM. Absorbance was measured using a Spectronic Genesys 5 spectrophotometer (Milton Roy Company, NY) at 540 nm. One unit is defined as the amount of enzyme required to reduce 1 µmol of Cr(VI) per minute.
The pH optimum of the enzyme was determined in an equimolar morpholineethanesulfonic acid (MES)-morpholinepropanesulfonic acid (MOPS)-Bicine (20 mM) buffer at 65°C. The temperature optimum of the enzyme was analyzed by adjusting the pH of a 20 mM MOPS buffer to pH 6.5 at various temperatures. Kinetic parameters were determined at the optimum pH and temperature over a 5-min incubation.
Purification of Cr(VI) reductase. All purification steps were carried out at room temperature with enzyme preparations stored at 4°C. Purification to homogeneity entailed five chromatographic steps, including anion-exchange, hydrophobic-interaction, dye-affinity, and size-exclusion chromatography, using an ACTA Prime purification system (GE Healthcare AB, Uppsala, Sweden).
Thermus scotoductus SA-01 was fractionated into periplasmic, cytoplasmic, and membrane fractions as previously described (23). Crude cytoplasmic proteins were applied to a DEAE-Toyopearl 650 M column (6 x 2.5 cm; Tosoh Corporation, Tokyo, Japan) equilibrated with 20 mM MOPS-NaOH buffer (pH 7; buffer A). Unbound proteins were eluted with 200 ml of the same buffer. Bound proteins were eluted with an isocratic NaCl concentration of 60 mM (100 ml) in the same buffer (flow rate, 300 ml h–1). Strongly bound proteins were eluted with buffer A containing 1 M NaCl (100 ml). Fractions with Cr(VI) reduction activity were pooled, dialyzed against 20 mM MOPS (pH 7.0), reloaded onto the DEAE column, and again eluted with a linear NaCl gradient of 0 to 0.1 M NaCl in buffer A (400 ml). Active fractions were pooled, and (NH4)2SO4 was added to a final concentration of 0.4 M.
For hydrophobic-interaction chromatography, a phenyl-Toyopearl 650 M (6 x 2.5 cm; Tosoh Corporation, Tokyo, Japan) column was equilibrated with 0.4 M (NH4)2SO4 in buffer A. Unbound proteins were eluted with the equilibration buffer (200 ml; flow rate, 300 ml h–1), after which bound proteins were eluted with a 200-ml linear gradient of 0.4 to 0 M (NH4)2SO4.
The dye-affinity chromatography step employed a Blue Sepharose CL-6B (Sigma-Aldrich, Steinheim, Germany) column (17 x 1.3 cm) equilibrated with buffer A (flow rate, 120 ml h–1). After binding of the dialyzed sample, the column was washed sequentially with 100 ml buffer A containing 0.1 M NaCl and buffer A containing 10 mM NAD+. The chromate reductase was then eluted with 100 ml of buffer A containing both 0.1 M NaCl and 10 mM NAD+. Active fractions were pooled and concentrated to 3 ml using ultrafiltration on a 10-kDa-cutoff cellulose membrane Vivaspin column (VivaScience, Hanover, Germany).
The final purification step was size-exclusion chromatography, whereby the native molecular mass of the chromate reductase was also determined. The concentrate was loaded onto a Sephacryl S-100 HR column (2.6 x 62 cm; Sigma-Aldrich, St. Louis, MO) equilibrated with 20 mM MOPS-NaOH (pH 7.0) containing 50 mM NaCl. Proteins were eluted with the same buffer at a flow rate of 0.5 ml min–1. Cytochrome c (12.4 kDa), chymotrypsin (25 kDa), and bovine serum albumin (66 kDa) were used as molecular mass standards.
Gel electrophoresis. Electrophoresis under denaturing conditions or sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) was performed according to the protocol described by Laemmli (15), using a 10% resolving gel and a 4% stacking gel. Precision Plus protein standards (Bio-Rad, Hercules, CA) were used as molecular mass markers, and proteins were visualized by staining of the polyacrylamide gels with Coomassie brilliant blue R-250.
Determination of flavin content. UV-visible spectra of the purified enzyme were recorded on a Beckman Coulter DU-800 spectrophotometer (Fullerton, CA). Flavin cofactor content was determined through thin-layer chromatography. The cofactor was released from the enzyme by autoclaving the sample, followed by centrifugation (14,000 x g for 10 min). The supernatant was applied to Silicagel 60 thin-layer chromatography aluminum plates (Merck, Darmstadt, Germany), using butanol-acetic acid-water (12:3:5) as the solvent. FMN and flavin adenine dinucleotide (FAD) were used as standards, and fluorescence spots were visualized using UV light.
Determination of N-terminal amino acid sequences. N-terminal amino acid sequencing was performed using an Applied Biosystems 4774A gas-phase sequencer (Foster City, CA) at the Protein Chemistry Facility of the Centro de Investigaciones Biologicas (CSIC, Madrid, Spain).
DNA library construction. Total genomic DNA (gDNA) of SA-01 was isolated using a modified SDS-proteinase K treatment method (29) and restriction digested using the endonuclease Sau3AI (New England BioLabs, Beverly, MA), using serial dilutions of enzyme ranging from 250 U ml–1 to 4.6 U ml–1 (15 min at 37°C). Digested DNA fragments ranging from 3 to 6 kbp were excised from the agarose gel and purified using a GFX PCR DNA and gel band purification kit (GE Healthcare, Buckinghamshire, United Kingdom).
pTrueBlue was linearized using BamHI (New England Biolabs) for 3 h at 37°C (1 U µl–1), followed by dephosphorylation using Antarctic phosphatase (New England BioLabs) (0.93 U µl–1; 4 h at 37°C). Size-fractionated DNA fragments were ligated into pTrueBlue at 1:2 and 1:3 vector/insert ratios, using an average 4.5-kb insert size for conversion of molar ratios to mass ratios, with T4 DNA ligase (New England BioLabs) (6 Weiss units) at 16°C for 12 h. Again, the plasmids were purified using a GFX PCR DNA and gel band purification kit.
Ligation mixtures were transformed into One Shot TOP10 E. coli competent cells (Invitrogen, Carlsbad, CA) according to the manufacturer's recommendations. Transformed cells were plated onto LB medium plates (100 µl plate–1) containing ampicillin (0.06 mg ml–1), isopropyl-β-D-thiogalactopyranoside (IPTG; 0.01 mg ml–1), and 5-bromo-4-chloro-3-indolyl-β-D-galactopyranoside (0.04 mg ml–1) and incubated overnight at 37°C to verify DNA ligation using blue-white selection.
Screening of genome library. An oligonucleotide probe was designed from the N-terminal amino acid sequence of the chromate reductase. A codon usage table was constructed from four complete protein coding sequences available for Thermus scotoductus from the GenBank DNA sequence database. Codon preference was analyzed using Kazusa CountCodon (20). The degenerate oligonucleotide probe (5' GCC CTS CTS TTY ACS CCC CTS GAD GGS 3', where S = G/C, Y = C/T, and D = A/G/T) was labeled with digoxigenin (DIG) at both the 5' and 3' ends and purified by high-performance liquid chromatography (TIB Molbiol, Berlin, Germany).
Colony hybridization using the DIG-labeled oligonucleotide probe was done as described in the DIG application manual for filter hybridization (Roche, Mannheim, Germany). Membranes were hybridized for 4 h with 10 ml DIG Easy Hyb solution containing 25 ng ml–1 DIG-labeled DNA probe at 33°C. Anti-DIG antibodies conjugated with alkaline phosphatase were used for the detection of DIG-labeled oligonucleotide probes. The membranes were incubated overnight with 4-nitroblue tetrazolium chloride (0.34 mg ml–1) and 5-bromo-4-chloro-3-indolylphosphate (0.175 mg ml–1) for colorimetric detection, and corresponding positive clones were identified on the master plates. Positive clones were inoculated into 5 ml LB medium supplemented with 0.1 mg ml–1 ampicillin and grown overnight at 37°C. Plasmid extractions were performed using a GeneJET plasmid miniprep kit (Fermentas, Glen Burnie, MD) per the manufacturer's instructions.
DNA sequencing and analysis. Plasmid inserts were sequenced by Inqaba Biotechnical Industries (South Africa), using a Spectrumedix SCE2410 genetic analysis system (SpectruMedix, State College, PA). Sequencing reactions were performed using a BigDye (v3.1) Terminator cycle sequencing kit (Applied Biosystems, Foster City, CA), using the universal T7 promoter primer and the pTrueBlueRev primer (5'-GGGATGCGCAGCTAATC-3'), which were located on the plasmid vector. Further sequencing was performed using a primer walking strategy. Sequences were analyzed using Vector NTI 9.0.0 (InforMax, Frederick, MD).
Homology searches against the GenBank database were performed using the basic local alignment search tool (BLAST) (3). Multiple alignments were done using CLUSTAL W multiple sequence alignment software (28). Secondary structure prediction was done using 3D-PSSM (10).
Cloning and heterologous expression of the chromate reductase. The complete open reading frame (ORF) for the chromate reductase was amplified by PCR from genomic DNA, using the Expand high-fidelity PCR system (Roche, Mannheim, Germany). PCRs were performed using the primers CrS_F_Nde (5' CAT ATG GCC TTG CTC TTC ACC CCC CTG GAA CTC 3') and CrS_R_Eco (5' GAA TTC CTA AAA CCC CCT TTG GTA CTG GGG GGG TAC 3'), which contained an NdeI and an EcoRI restriction site, respectively (underlined). Reaction mixtures (50 µl) consisted of 10x Expand high-fidelity buffer with 15 mM MgCl2 (5 µl), deoxynucleoside triphosphates (0.8 mM), Expand high-fidelity enzyme mix (1 µl), 50 ng of gDNA, and 0.2 µM of both the forward and reverse primers. Reaction conditions consisted of an initial denaturing step at 95°C for 5 min, followed by 25 cycles of denaturing at 95°C (30 s), annealing at 65°C (40 s), and elongation at 72°C (1.5 min), with a final extension at 72°C for 10 min.
The PCR product was ligated into pGEM-T Easy (Promega, Madison, WI) vector at a 1:1 molar ratio overnight at 4°C according to the manufacturer's instructions and proliferated in One Shot TOP10 E. coli competent cells (Invitrogen, Carlsbad, CA). Plasmids were isolated using a GeneJet miniprep kit (Fermentas, Glen Burnie, MD). Plasmids containing inserts were double digested with the restriction enzymes NdeI (0.5 U µl–1; Fermentas) and EcoRI (0.5 U µl–1; Fermentas) at 37°C (3 h) for ligation into pET22b(+), which was similarly digested. Inserts and digested pET22b(+) vectors were cleaned from a low-melting-point agarose gel by using a GFX PCR DNA and gel band purification kit. Cohesive end ligations were performed at a 1:1 molar ratio, using 40 ng of vector. Ligations were performed in 20-µl reaction volumes overnight at 4°C with 1.5 Weiss U µl–1 T4 DNA ligase (New England Biolabs, Beverly, MA). Ligation mixtures were again transformed into TOP10 E. coli cells, and positive clones were identified through plasmid isolation and restriction digestion as described above.
The pET22-chromate reductase construct was transformed into E. coli BL21(DE3) competent cells (Lucigen, Middleton, WI) for expression. Positive clones were identified through selection on LB plates containing 100 µg ml–1 ampicillin and inoculated into LB medium also containing the same appropriate antibiotic. Cells were incubated with shaking (200 rpm) until an optical density at 600 nm of approximately 0.8 to 1 was reached. IPTG was added as an inducer to a final concentration of 1 mM, and cells were grown for an additional 4 h. Cells were harvested through centrifugation (8,000 x g, 10 min) and washed using 20 mM MOPS-NaOH (pH 7).
Harvested cells were resuspended in 20 mM MOPS-NaOH (pH 7) and were broken by ultrasonic treatment for 5 min (100 W), after which unbroken cells and debris were removed through centrifugation (8,000 x g for 10 min). The soluble fraction (cytoplasm) was separated from the insoluble fraction (membranes) through ultracentrifugation (100,000 x g, 90 min). The recombinant chromate reductase was purified from the E. coli proteins through a single heat denaturation step of 1.5 h at 70°C.
Analytical techniques. Protein concentrations were determined using the bicinchoninic acid (BCA) method (26). A BCA protein assay kit and a Micro BCA protein assay kit from Pierce (Rockford, IL) were used according to the manufacturer's instructions, with bovine serum albumin as the standard.
DNA concentrations were determined using a NanoDrop spectrophotometer (NanoDrop Technologies, Wilmington, DE).
NAD(P)H consumption was related to Cr(VI) reduction by measuring the oxidation of NADH through the decrease in absorbance at 340 nm, using a Beckman Coulter DU-800 spectrophotometer or a Beckman Coulter DU-650 spectrophotometer (Fullerton, CA) within an anoxic Coy anaerobic chamber (Coy Laboratory Products, Grass Lake, MI). The NAD(P)H concentration was determined from the A340 by using the extinction coefficient 6.3 mM cm–1 (34).
Nucleotide sequence accession number. The DNA sequence reported here has been submitted to the EMBL nucleotide sequence database under accession number AM902709.
| RESULTS |
|---|
|
|
|---|
The cytoplasmic chromate reductase was purified from the crude soluble fraction of T. scotoductus to homogeneity through DEAE-Toyopearl, phenyl-Toyopearl, Blue Sepharose, and Sephacryl S100HR chromatography (Table 1), with an overall purification of 450-fold relative to the crude cytoplasmic fraction and with a final yield of 9.1%.
|
Activity corresponded with a light yellow color resistant to ultrafiltration, with UV-visible absorbance maxima at 375 nm and 460 nm, indicative of flavoproteins (Fig. 1). The noncovalently bound flavin was identified as FMN through thin-layer chromatography (data not shown).
|
|
|
|
A putative ribosome binding site (GGAGG) was identified directly upstream of the ORF but uncharacteristically close to the start codon, with only a 1-nucleotide (nt) separation. The 5'-flanking region of the ORF also included putative E. coli
70-like –10 and –35 hexamer promoter elements approximately 100 nt upstream of the translation initiation site. A 9-bp inverted repeat was detected immediately downstream of the ORF, indicating a putative transcription termination sequence.
Amino acid sequence comparison. BLAST analysis of the predicted amino acid sequence against the RCSB Protein Data Bank showed the highest sequence identity (50%) to be with an OYE homologue (YqjM) from Bacillus subtilis involved in the oxidative stress response through the reductive degradation of various xenobiotics (7, 12). High identity (45%) with the xenobiotic reductase (XenA) from Pseudomonas putida 86, catalyzing the NAD(P)H-dependent reduction of electrophilic xenobiotics (9), was also found. Multiple alignments of the gene product with the predicted flavin oxidoreductase from T. thermophilus HB8 (NCBI:YP 143423), XenA from P. putida 86 (PDB:2H8X), YqjM from B. subtilis (PDB:1Z41A), and a predicted NADH:flavin oxidoreductase from Geobacter metallireducens (NCBI:YP 385521) are shown in Fig. 3.
|
|
| DISCUSSION |
|---|
|
|
|---|
N-terminal sequencing of the chromate reductase revealed the absence of an N-terminal methionine residue. Whether this is due to the uncharacteristically closely spaced ribosome binding site or to posttranslational modification is unknown. The chromate reductase is encoded by an ORF of 1,050 bp with putative promoter elements and a ribosome binding site located in the 5' regulatory flanking region. The putative –10 and –35 hexamers showed high similarity to E. coli
70 promoter consensuses (TATAAT and TTGACA, respectively). Comparison of the primary structure of the chromate reductase with the PDB showed the highest homology to the OYE homologues YqjM from Bacillus subtilis (7, 12) and XenA from Pseudomonas putida (9). Both of these reductases have been shown to reduce a variety of xenobiotic substrates. Due to the broad substrate specificity of YqjM and other members of the family, as well as their involvement in the oxidative stress response, Fitzpatrick and coworkers (12) speculated that it is unlikely that these enzymes have a single specific physiological substrate in vivo and that these enzymes could function in the maintenance of the cellular redox state. Reduction of Cr(VI) by cellular components to Cr(V) as well as a transiently formed Cr(V) intermediate before complete reduction to Cr(III) by some flavoenzymes is thought to be a major cause of chromate oxidative stress and carcinogenesis through the formation of ROS (16, 24). The NfsA (nitroreductase) from E. coli has been shown to be able to preempt ROS generation and minimize oxidative stress during chromate reduction, protecting against chromate toxicity as well as increasing Cr(VI) tolerance (1).
The high degree of similarity between the chromate reductase and the OYE homologues suggests the characteristic (β
)8-barrel (TIM barrel) fold. Secondary structure prediction also indicated eight alternating β-sheets and
-helixes (10). (β
)8-Barrel-folded proteins catalyze a variety of biochemical reactions and are among the most frequent folds observed (19, 31).
Multiple alignments of the chromate reductase with these enzymes showed that the sequence identities corresponded to the functionally important amino acids identified in YqjM and XenA involved in lining the active site, especially those involved in the interaction between the apoprotein and FMN. In YqjM, a sulfate ion from the crystallization solution occupied the catalytic site on the isoalloxazine ring of the FMN, and in XenA a sulfate ion could be modeled into the same position. The residues capable of interaction with the sulfate ion are also conserved in the chromate reductase (specifically His173, His176, and Tyr178) (Fig. 4). The structural similarity between sulfate and chromate could be an indication of how chromate binds as a substrate in the catalytic site. In addition, Kitzing and coworkers (12) showed that the active site of YqjM is hydrophobic, wide open, and easily accessible and that the huge substrate binding pocket allows the binding of a variety of different substrates (including the possibility of other proteins) to control the cellular redox state.
| ACKNOWLEDGMENTS |
|---|
We thank Victor Parro (Centro de Astrobiologica, Spain) for help with the N-terminal sequencing and for helpful advice as well as José Berenguer (Centro de Biología Molecular, Spain) for help with heterologous expression studies.
| FOOTNOTES |
|---|
Published ahead of print on 8 February 2008. ![]()
| REFERENCES |
|---|
|
|
|---|
: construction of pTrueBlue and M13TrueBlue cloning vectors. Gene 213:83-91.[CrossRef][Medline]
)8-barrel fold. Curr. Opin. Chem. Biol. 7:694-701.[CrossRef][Medline]
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Appl. Environ. Microbiol. | Infect. Immun. | Eukaryot. Cell |
|---|---|---|
| Mol. Cell. Biol. | J. Virol. | Microbiol. Mol. Biol. Rev. |
| ALL ASM JOURNALS |